Search Results - "Gamvrellis, Anita"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors by Fifis, Theodora, Gamvrellis, Anita, Crimeen-Irwin, Blessing, Pietersz, Geoffrey A, Li, Jie, Mottram, Patricia L, McKenzie, Ian F. C, Plebanski, Magdalena

    Published in The Journal of immunology (1950) (01-09-2004)
    “…Infection can protect against subsequent disease by induction of both humoral and cellular immunity, but inert protein-based vaccines are not as effective. In…”
    Get full text
    Journal Article
  2. 2

    Vaccines that facilitate antigen entry into dendritic cells by Gamvrellis, Anita, Leong, David, Hanley, Jennifer C, Xiang, Sue D, Mottram, Patricia, Plebanski, Magdalena

    Published in Immunology and cell biology (01-10-2004)
    “…Although vaccines have been highly successful in preventing and treating many infectious diseases (including smallpox, polio and diphtheria) diseases prevalent…”
    Get full text
    Journal Article
  3. 3

    Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep by Gamvrellis, Anita, Gloster, Simone, Jefferies, Meryem, Mottram, Patricia L., Smooker, Peter, Plebanski, Magdalena, Scheerlinck, Jean-Pierre Y.

    Published in Veterinary immunology and immunopathology (01-09-2013)
    “…Most adjuvants require danger signals to promote immune responses against vaccine antigens. Our previous studies have characterised a powerful nano-particulate…”
    Get full text
    Journal Article
  4. 4

    Phenotypic analysis of ovine antigen presenting cells loaded with nanoparticles migrating from the site of vaccination by Gamvrellis, Anita, Walsh, Katrina, Tatarczuch, Liliana, Smooker, Peter, Plebanski, Magdalena, Scheerlinck, Jean-Pierre Y.

    Published in Methods (San Diego, Calif.) (01-05-2013)
    “…Virus-sized particulate adjuvants such as ISCOMs, polystyrene nanoparticles and virus-like particles have been shown to target dendritic cells, resulting in…”
    Get full text
    Journal Article
  5. 5

    Systemic immune responses in sheep, induced by a novel nano-bead adjuvant by Scheerlinck, Jean-Pierre Y., Gloster, Simone, Gamvrellis, Anita, Mottram, Patricia L., Plebanski, Magdalena

    Published in Vaccine (20-02-2006)
    “…Although a number of adjuvants are currently approved for use in veterinary species, only alum has been widely used in humans. While it induces strong antibody…”
    Get full text
    Journal Article
  6. 6

    Delivery of a heterologous antigen by a registered Salmonella vaccine (STM1) by Bachtiar, Endang W, Sheng, Kuo-Ching, Fifis, Theodora, Gamvrellis, Anita, Plebanski, Magdalena, Coloe, Peter J, Smooker, Peter M

    Published in FEMS microbiology letters (24-10-2003)
    “…STM1 is an aro A − attenuated mutant of Salmonella enterica serovar Typhimurium, and is a well-characterised vaccine strain available to the livestock industry…”
    Get full text
    Journal Article
  7. 7

    Delivery of a heterologous antigen by a registered Salmonella vaccine (STM1) by Bachtiar, Endang W, Kuo-Ching, Sheng, Fifis, Theodora, Gamvrellis, Anita, Plebanski, Magdalena, Coloe, Peter J, Smooker, Peter M

    Published in FEMS microbiology letters (01-10-2003)
    “…STM1 is an aro A− attenuated mutant of Salmonella enterica serovar Typhimurium, and is a well-characterised vaccine strain available to the livestock industry…”
    Get full text
    Journal Article